South Australian Cancer Registry (Australia)
Database Contact Data
SA Cancer Registry
Contact: Helen Thomas
Email: helen.thomas2@sa.gov.au
Alternate Contact
SA Cancer Registry Manager
Email: WellbeingSACCSACancerRegistry@sa.gov.au
References of Studies Using/Describing Database
1. Tempo JA, Sii S, Ischia J, Bolton DM, D'Onise K, Meng R, Watson DI, O'Callaghan M. Lessons from a population‐based bladder cancer registry: exploring why survival is not improving. BJU international. 2024 Jun;133(6):699-708.
2. Mashtoub S, Ullah S, Collinson A, Singh GR, Clark J, Leemaqz S, Paltiel O, Roder DM, Saxon B, McKinnon R, Pandol SJ. Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples. Cancers. 2024 May 29;16(11):2057.
3. Tiruye T, Roder D, FitzGerald LM, O'Callaghan M, Moretti K, Caughey GE, Beckmann K. Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study. The Prostate. 2024 May 26.
4. Venugopal K, Youlden D, Te Marvelde L, Meng R, Aitken J, Evans S, Kostadinov I, Nolan R, Thomas H, D'Onise K. Twenty years of melanoma in Victoria, Queensland, and South Australia (1997–2016). Cancer Epidemiology. 2023 Apr 1;83:102321.
5. Gheybi K, Buckley E, Vitry A, Roder D. Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer. Frontiers in Public Health. 2023;11.
6. Lal A, Gao L, Tan E, McCaffrey N, Roder D, Buckley E. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study. Plos one. 2022 Dec 21;17(12):e0279177.
7. Clark RA, Lui S. Does Cancer Treatment Break Your Heart? A Linked Health Data Analysis of Thecharacteristics and Survival of Patients Who Have Developed Cardiovascular Disease Post Cancer Treatment. Circulation. 2022 Nov 8;146(Suppl_1):A14602-.
8. Gheybi K, Buckley E, Vitry A, Roder D. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis. Cancer Epidemiology. 2022 Oct 1;80:102246.
9. Beckmann K, Kearney AM BJ, Yeung D, Hiwase D, Li M, Roder DM. Changes in five‐year survival for people with acute leukaemia in South Australia, 1980–2016. Medical Journal of Australia. 2022 Apr 4;216(6):296-302.
10. Lal A, McCaffrey N, Gold L, Roder D, Buckley E. Variations in utilisation of colorectal cancer services in South Australia indicated by MBS/PBS benefits: a benefit incidence analysis. Australian and New Zealand Journal of Public Health. 2022 Apr;46(2):237-42.
Mar 17, 2021: How useful is B.R.I.D.G.E. for your research?
Curious to see how B.R.I.D.G.E. has been used by the research community? View our citations page for a list of peer reviewed articles, textbooks and presentations where our resource was a useful reference.
Mar 15, 2021: Read about our newest database profile from IBM®
The IBM® MarketScan® Hospital Drug Database provides researchers with inpatient drug utilization data from hospital discharge records since 2002. This database is derived primarily from hospital billing systems from US hospitals. These data allow researchers to evaluate drug use in the inpatient and outpatient settings, including hospital use patterns, switching behavior, combination therapy and patient characteristics.